Search results
Services for journal authors. With a portfolio of some 450 international academic journals, De Gruyter is proud to be able to offer a full range of high-quality, state-of-the-art services, to support you in publishing your article. Learn more →.
Publications. De Gruyter publishes over 1,100 books and over 16,000 journal articles every year, including more than 200 books and 6,000 articles in open access, across the humanities, sciences, technology, medicine and social sciences, as well as a wide range of digital media, including 70 databases and online reference works. Books. Our book ...
De Gruyter offers libraries and vendors excellent titles across 29 subject areas, a deep backlist, and partnerships with prominent publishers. Our Book Archive contains over 50,000 titles spanning our 270-year history, from 1749 until today.
Feb 13, 2018 · From social science perspectives on Facebook to the philosophical implications of augmented reality, here are 10 handpicked new open access books available from De Gruyter.
Deruyter, Sarah, Van Biervliet, Stephanie and De Guchtenaere, Ann. "Response to vitamin D replacement therapy in obese children and adolescents with vitamin D deficiency: a randomized controlled trial" Journal of Pediatric Endocrinology and Metabolism, vol. 36, no. 5, 2023, pp. 458-465.
eJournals. Unmistakable value, article for article – De Gruyter’s 450 journals are an invaluable resource for any library, representing the best scientific and scholarly research available. About 450 journals – 340 available as subscription, 107 open access.
Discover our open access journal portfolio. De Gruyter is home to around 100 fully open access journals across STEM and HSS disciplines. For most of our fully open access journals, we apply an article processing charge (APC) to cover the publication costs.
In this paper, we focus on the human upper limb rehabilitation scheme that utilizes the concept ofteleoperation. Teleoperation can help the therapist demonstrate different rehab exercises to a different group of people at the same time remotely.
Major depressive disorder is a genetic susceptible disease, and a psychiatric syndrome with a high rate of incidence and recurrence. Because of its complexity concerning etiology and pathogenesis, the cure rate of first-line antidepressants is low.
Barthelemy, A., Sencio, V., Soulard, D., Deruyter, L., Faveeuw, C., Le Goffic, R., and Trottein, F. (2018). Interleukin-22 immunotherapy during severe influenza enhances lung tissue integrity and reduces secondary bacterial systemic invasion.
